Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Acadia Healthcare Company, Inc.ACHC · Entity 4312 | Director | July 29, 2022 | August 02, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Acadia Healthcare Company, Inc.
Report date July 29, 2022 · Filed August 02, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 31,769 |
Reported balance
After 2022-07-29 transaction · row 1
1 source rowRow 1 · 2022-07-29 · Sale · Disposed 6,000 · Balance 31,769 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.40 to $83.48, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.40 to $83.48, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 29, 2022 Filed Aug 2, 2022 17:01 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | SaleCommon Stock | 6,000 | $83.42 | $500,520.00 |
DisclosureSEC source: 0000899243-22-027403 · doc4.xml · nonDerivative · entry 1 Petrie William M · CIK 0001302671 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,769 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.40 to $83.48, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 19, 2022 Filed May 20, 2022 17:08 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 2,303 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-019063 · doc4.xml · nonDerivative · entry 1 Petrie William M · CIK 0001302671 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,769 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 19, 2023. Read SEC document |
| May 06, 2021 Filed May 7, 2021 17:05 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 2,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-018715 · doc4.xml · nonDerivative · entry 1 Petrie William M · CIK 0001302671 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,466 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 6, 2022. Read SEC document |
| May 07, 2020 Filed May 8, 2020 17:02 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 6,609 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-012426 · doc4.xml · nonDerivative · entry 1 Petrie William M · CIK 0001302671 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,916 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 7, 2021. Read SEC document |
| May 02, 2019 Filed May 6, 2019 17:47 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 4,943 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-012253 · doc4.xml · nonDerivative · entry 1 Petrie William M · CIK 0001302671 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,307 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 2, 2020. Read SEC document |
| May 03, 2018 Filed May 4, 2018 17:05 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 4,125 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-011536 · doc4.xml · nonDerivative · entry 1 Petrie William M · CIK 0001302671 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,364 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 3, 2019. Read SEC document |
| May 25, 2017 Filed May 26, 2017 17:02 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 3,752 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-014572 · doc4.xml · nonDerivative · entry 1 Petrie William M · CIK 0001302671 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,239 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 25, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.